Logo image of GSUN

GOLDEN SUN HEALTH TECHNOLOGY (GSUN) Stock Fundamental Analysis

NASDAQ:GSUN - Nasdaq - KYG4013A1159 - Common Stock - Currency: USD

3.16  -0.1 (-3.07%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to GSUN. GSUN was compared to 71 industry peers in the Diversified Consumer Services industry. GSUN has a bad profitability rating. Also its financial health evaluation is rather negative. GSUN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

GSUN had negative earnings in the past year.
In the past year GSUN has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: GSUN reported negative net income in multiple years.
In multiple years GSUN reported negative operating cash flow during the last 5 years.
GSUN Yearly Net Income VS EBIT VS OCF VS FCFGSUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

GSUN's Return On Assets of -32.15% is on the low side compared to the rest of the industry. GSUN is outperformed by 71.83% of its industry peers.
With a Return On Equity value of -759.03%, GSUN is not doing good in the industry: 81.69% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -32.15%
ROE -759.03%
ROIC N/A
ROA(3y)-20.23%
ROA(5y)-6.12%
ROE(3y)-223.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GSUN Yearly ROA, ROE, ROICGSUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

With a Gross Margin value of 28.81%, GSUN is not doing good in the industry: 66.20% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of GSUN has declined.
GSUN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.54%
GM growth 5Y-15.35%
GSUN Yearly Profit, Operating, Gross MarginsGSUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

GSUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GSUN has less shares outstanding
GSUN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for GSUN is higher compared to a year ago.
GSUN Yearly Shares OutstandingGSUN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
GSUN Yearly Total Debt VS Total AssetsGSUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

GSUN has an Altman-Z score of -1.44. This is a bad value and indicates that GSUN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.44, GSUN is doing worse than 67.61% of the companies in the same industry.
A Debt/Equity ratio of 3.74 is on the high side and indicates that GSUN has dependencies on debt financing.
GSUN has a Debt to Equity ratio of 3.74. This is in the lower half of the industry: GSUN underperforms 76.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.74
Debt/FCF N/A
Altman-Z -1.44
ROIC/WACCN/A
WACC7.59%
GSUN Yearly LT Debt VS Equity VS FCFGSUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

GSUN has a Current Ratio of 0.71. This is a bad value and indicates that GSUN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.71, GSUN is doing worse than 69.01% of the companies in the same industry.
A Quick Ratio of 0.69 indicates that GSUN may have some problems paying its short term obligations.
GSUN's Quick ratio of 0.69 is on the low side compared to the rest of the industry. GSUN is outperformed by 67.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.69
GSUN Yearly Current Assets VS Current LiabilitesGSUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.26% over the past year.
GSUN shows a strong growth in Revenue. In the last year, the Revenue has grown by 65.03%.
Measured over the past years, GSUN shows a decrease in Revenue. The Revenue has been decreasing by -7.70% on average per year.
EPS 1Y (TTM)39.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)65.03%
Revenue growth 3Y-12.23%
Revenue growth 5Y-7.7%
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GSUN Yearly Revenue VS EstimatesGSUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GSUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GSUN Price Earnings VS Forward Price EarningsGSUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GSUN Per share dataGSUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GSUN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GOLDEN SUN HEALTH TECHNOLOGY

NASDAQ:GSUN (7/11/2025, 8:19:40 PM)

3.16

-0.1 (-3.07%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)08-13 2024-08-13
Earnings (Next)N/A N/A
Inst Owners0.26%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap6.26M
AnalystsN/A
Price TargetN/A
Short Float %1.45%
Short Ratio0.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 6.26
P/tB 6.26
EV/EBITDA N/A
EPS(TTM)-2.76
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.54
FCFYN/A
OCF(TTM)-2.48
OCFYN/A
SpS7
BVpS0.51
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.15%
ROE -759.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.81%
FCFM N/A
ROA(3y)-20.23%
ROA(5y)-6.12%
ROE(3y)-223.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.54%
GM growth 5Y-15.35%
F-Score3
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 3.74
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 143.69%
Cap/Sales 0.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.69
Altman-Z -1.44
F-Score3
WACC7.59%
ROIC/WACCN/A
Cap/Depr(3y)136.18%
Cap/Depr(5y)169.28%
Cap/Sales(3y)2.32%
Cap/Sales(5y)2.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)65.03%
Revenue growth 3Y-12.23%
Revenue growth 5Y-7.7%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y58.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.29%
OCF growth 3YN/A
OCF growth 5YN/A